Back

HFWM: Proteomic remodeling in the failing left ventricle adapting to dyssynchrony

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pathophysiology and mechanisms 4 Ventricular Remodelling HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Karin Ljung

Karolinska Institute, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail
Prevalence of echocardiographic findings for restrictive filling pattern in transthyretin cardiac amyloidosis
Mr F. Edbom (Umea, SE)
Abstract Slides Video
Presentation thumbnail
Exercise-induced hemodynamic changes in healthy middle-aged adults: insights from exercise echocardiography
Doctor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
The anti-remodeling effect of sacubitril/valsartan in myocardial samples of end-stage heart failure patients
Doctor D. Nagy (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Ratio between early diastolic filling velocity and global longitudinal strain is associated with ventricular remodeling and heart failure in short and long term follow up
Associate Professor M. Dekleva (Belgrade, RS) Doctor A. Stevanovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Mechanical dyssynchrony in dilated cardiomyopathy patients admitted for decompensated heart failure
Doctor A. Dadarlat-Pop (Cluj Napoca, RO)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pathophysiology and mechanisms 4

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Nineteen proteins differentially identify phases of myocardial remodeling in a rat model of pressure overload induced hypertrophy
thumbnail
Congress Presentation
Plasma proteomics in acute heart failure - a step towards a mechanistic understanding of the disease
thumbnail
Congress Presentation
Locally increased dysferlin expression improves left-ventricular function by stabilizing membrane nanodomains of cardiomyocytes in the myocardial infarction border zone

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources